County Durham women fall ill as fake Botox beautician apologises

County Durham women fall ill as fake Botox beautician apologises

Aesthetic beautician Gemma Gray apologized for leaving one woman fighting for her life and several others seriously ill in the hospital after injecting them with Toxpia, an illegal Botox-type anti-wrinkle treatment. The BBC revealed the woman behind the jabs, and two victims shared their harrowing stories.

Kaylie Bailey, a 36-year-old mother of three from Peterlee, County Durham, paid Gray £75 for three “Botox” injections, only to find out that the bargain deal had disastrous consequences. Soon after the treatment, Bailey struggled to see, and doctors initially misdiagnosed her condition. Eventually, Bailey was diagnosed with botulism, a rare and life-threatening condition caused by bacterial contamination.

After Bailey’s ordeal, she contacted Gray, who claimed it was a “nationwide problem with the product.” Similarly, Paula Harrison, a 54-year-old mother-of-two, also experienced severe health issues after visiting Gray at her salon in Blackhall, Co Durham. Harrison faced throat closure and difficulty eating, requiring admission to the hospital and treatment with an anti-toxin. Harrison criticized Gray for playing with people’s lives and worried about the potentially fatal repercussions of her actions.

Gray, who operates Belissimo Aesthetics, used an illegal type of botulinum toxin on her patients, despite seven legal products licensed for use in the UK, including Botox. She told clients that Toxpia was a “new type of Botox” and charged a low price for the treatment. Gray expressed regret to her clients for the harm caused and indicated it was a national issue. While an investigation by the UK Health Security Agency is ongoing, the Department of Health and Social Care warned of the risks posed by inadequately trained operators in the cosmetic sector and advised individuals to research practitioners and verify the legality of the products used

Read the full article from The BBC here: Read More